These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21942520)

  • 21. Development of a micro-turbulent flow chromatography focus mode method for drug quantitation in discovery bioanalysis.
    Turnpenny P; Fraier D; Chassaing C; Duckworth J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):131-40. PubMed ID: 17574938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced resolution triple-quadrupole mass spectrometry for fast quantitative bioanalysis using liquid chromatography/tandem mass spectrometry: investigations of parameters that affect ruggedness.
    Jemal M; Ouyang Z
    Rapid Commun Mass Spectrom; 2003; 17(1):24-38. PubMed ID: 12478552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
    Xue YJ; Akinsanya JB; Liu J; Unger SE
    Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined approach for high-throughput preparation and analysis of plasma samples from exposure studies.
    Briem S; Martinsson S; Bueters T; Skoglund E
    Rapid Commun Mass Spectrom; 2007; 21(13):1965-72. PubMed ID: 17526069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approach to evaluating dried blood spot sample stability during drying process and discovery of a treated card to maintain analyte stability by rapid on-card pH modification.
    Liu G; Ji QC; Jemal M; Tymiak AA; Arnold ME
    Anal Chem; 2011 Dec; 83(23):9033-8. PubMed ID: 21995953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of drug concentrations in plasma by a highly automated, generic and flexible protein precipitation and liquid chromatography/tandem mass spectrometry method applicable to the drug discovery environment.
    O'Connor D; Clarke DE; Morrison D; Watt AP
    Rapid Commun Mass Spectrom; 2002; 16(11):1065-71. PubMed ID: 11992509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization.
    Remane D; Meyer MR; Wissenbach DK; Maurer HH
    Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3103-8. PubMed ID: 20941756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case studies: the impact of nonanalyte components on LC-MS/MS-based bioanalysis: strategies for identifying and overcoming matrix effects.
    Li F; Ewles M; Pelzer M; Brus T; Ledvina A; Gray N; Koupaei-Abyazani M; Blackburn M
    Bioanalysis; 2013 Oct; 5(19):2409-41. PubMed ID: 24066625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry.
    Yu K; Little D; Plumb R; Smith B
    Rapid Commun Mass Spectrom; 2006; 20(4):544-52. PubMed ID: 16419023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel on-line solid-phase extraction approach integrated with a monolithic column and tandem mass spectrometry for direct plasma analysis of multiple drugs and metabolites.
    Zang X; Luo R; Song N; Chen TK; Bozigian H
    Rapid Commun Mass Spectrom; 2005; 19(22):3259-68. PubMed ID: 16220526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting the stability of drugs and drug metabolites in biological matrices.
    Briscoe CJ; Hage DS
    Bioanalysis; 2009 Apr; 1(1):205-20. PubMed ID: 21083197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioanalysis without sample cleanup or chromatography: the evaluation and initial implementation of direct analysis in real time ionization mass spectrometry for the quantification of drugs in biological matrixes.
    Yu S; Crawford E; Tice J; Musselman B; Wu JT
    Anal Chem; 2009 Jan; 81(1):193-202. PubMed ID: 19117450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct analysis of plasma samples for drug discovery compounds using mixed-function column liquid chromatography tandem mass spectrometry.
    Hsieh Y; Bryant MS; Gruela G; Brisson JM; Korfmacher WA
    Rapid Commun Mass Spectrom; 2000; 14(15):1384-90. PubMed ID: 10920359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated sample preparation and LC-MS for high-throughput ADME quantification.
    O'Connor D
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):52-8. PubMed ID: 11865673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capillary electrophoresis-mass spectrometry, an attractive tool for drug bioanalysis and biomarker discovery.
    Servais AC; Crommen J; Fillet M
    Electrophoresis; 2006 Jul; 27(13):2616-29. PubMed ID: 16817163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive determination of a pharmaceutical compound and its metabolites in human plasma by ultra-high performance liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction.
    Heinig K; Wirz T; Bucheli F; Monin V; Gloge A
    J Pharm Biomed Anal; 2011 Mar; 54(4):742-9. PubMed ID: 21051172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery.
    Mei H; Hsieh Y; Nardo C; Xu X; Wang S; Ng K; Korfmacher WA
    Rapid Commun Mass Spectrom; 2003; 17(1):97-103. PubMed ID: 12478560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data-driven approach for cross-species comparative metabolite exposure assessment: how to establish fundamental bioanalytical parameters for the peak area ratio method.
    Gao H; Obach RS
    Bioanalysis; 2014 Mar; 6(5):641-50. PubMed ID: 24620806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moving from fast to ballistic gradient in liquid chromatography/tandem mass spectrometry pharmaceutical bioanalysis: Matrix effect and chromatographic evaluations.
    De Nardi C; Bonelli F
    Rapid Commun Mass Spectrom; 2006; 20(18):2709-16. PubMed ID: 16921566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing a robust ultrafiltration-LC-MS/MS method for quantitative analysis of unbound vadimezan (ASA404) in human plasma.
    Li W; Lin H; Smith HT; Tse FL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1927-33. PubMed ID: 21680264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.